Innovative Implant Uses Oxygenation to Treat Type 1 Diabetes
A new implant system developed at Cornell University offers a promising approach to treating type 1 diabetes by oxygenating insulin-producing cells, potentially reducing dependence on immunosuppressive drugs and enabling better disease management.
Researchers at Cornell University have developed a groundbreaking implant system designed to treat type 1 diabetes by enhancing oxygen supply to insulin-producing cells. This novel device delivers oxygen directly to densely packed pancreatic cells, allowing them to function effectively without needing immunosuppressive drugs. The system consists of a cylindrical capsule housing transplanted insulin-secreting cells and a compact electrochemical oxygen generator the size of a dime, which can be removed as needed. A nanofibrous membrane protects the cells from immune attacks, while a permeable membrane ensures the transfer of oxygen and nutrients.
The technology builds upon previous implantable devices developed in the lab of Professor Minglin Ma, who has previously achieved success controlling blood sugar in diabetic mice but faced limitations due to oxygen deprivation leading to cell death. By introducing the oxygen generator, the new system maintains an adequate oxygen supply, significantly prolonging the survival and functionality of transplanted cells.
The device has been successfully tested in rat models, demonstrating its potential to support high-density cell transplantation and immune protection. Future steps include testing in pig models and exploring applications for other chronic diseases requiring local delivery of therapeutic molecules.
This approach could revolutionize treatment options for the approximately 2 million people with type 1 diabetes in the U.S., enabling more effective and potentially curative therapies without the risks associated with immune suppression. The implant's ability to provide tighter sugar control could allow patients to manage their condition naturally, with fewer daily interventions.
The system's innovative design emphasizes immune protection, efficient oxygenation, and compatibility with long-term use, paving the way for advanced cell therapies. The research team is also exploring broader applications, including delivering other therapeutic proteins and addressing autoimmune and inflammatory diseases.
Source: https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Detection of Alzheimer's Disease Using Brain and Blood Biomarkers in Middle Age
New research shows that Alzheimer's disease biomarkers can be detected in the brain and blood during middle age, paving the way for earlier diagnosis and intervention strategies. This breakthrough could transform how the disease is screened and managed in the future.
Extreme Spring Pollen Levels in Europe Highlight Growing Allergy Concerns
European regions are experiencing unprecedented high levels of pollen this spring, driven by climate change and environmental factors, increasing allergy and respiratory health risks across the continent.
New Insight into Fat Cells: Internal Receptors Regulate Lipolysis
Scientists have uncovered that fat cells possess internal receptors that self-regulate fat breakdown, revealing a new intracrine signaling mechanism with potential therapeutic implications for metabolic diseases.
Gut Microbe Balance May Be Crucial in Early-Onset Colorectal Cancer, Mouse Study Finds
Research reveals that the balance of gut microbes and their metabolites may influence the risk of developing early-onset colorectal cancer. A mouse study highlights potential microbiome-targeted interventions for prevention.